First, primary and immortalized mouse hepatocytes were used to explore the role of BRD4 in the pathogenesis of MASH, and this in vitro cellular model may not be representative of in vivo metabolic conditions. This evidence concerns the gene BRD4 and metabolic dysfunction-associated steatohepatitis.